Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL601418 | 0.89 | TSHR (0.45) | ALDH1A1TSHRTHRB | |
| SCHEMBL9162961 | 0.87 | TSHR (0.43) | ALDH1A1TSHRTHRB | |
| SCHEMBL5068871 | 0.87 | TSHR (0.43) | ALDH1A1TSHRTHRB | |
| SCHEMBL28528795 | 0.85 | TSHR (0.42) | ALDH1A1TSHRTHRB | |
| SCHEMBL1873811 | 0.84 | ALDH1A1 (0.46) | ALDH1A1TSHRTHRBCYP2D6CYP2C19 | |
| SCHEMBL11378652 | 0.83 | TSHR (0.39) | ALDH1A1TSHRTHRB | |
| Methacrylic Acid SCHEMBL6545289 | 0.83 | TSHR (0.41) | ALDH1A1TSHRTHRB | |
| SCHEMBL8968857 | 0.83 | TSHR (0.41) | ALDH1A1TSHRTHRB | |
| SCHEMBL2515346 | 0.83 | ALDH1A1 (0.44) | ALDH1A1TSHRTHRB | |
| SCHEMBL15306386 | 0.82 | TSHR (0.44) | ALDH1A1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008914-A1 | CURABLE COMPOSITION, MOLDED BODY, SILICONE HYDROGEL, AND METHOD FOR PRODUCING SILICONE HYDROGEL | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-08 | — | — | US | claimed |
| EP-4644444-A1 | CURABLE COMPOSITION, MOLDED BODY, SILICONE HYDROGEL, AND METHOD FOR PRODUCING SILICONE HYDROGEL | Mitsubishi Chemical Corporation (JP) | 2025-11-05 | — | — | EP | claimed |
| EP-4617318-A1 | RESIN COMPOSITION AND MOLDED BODY | MCPP Innovation LLC (JP) | 2025-09-17 | — | — | EP | claimed |
| US-20250257215-A1 | RESIN COMPOSITION AND MOLDED ARTICLE | MCPP INNOVATION LLC (JP) | 2025-08-14 | — | — | US | claimed |
| US-20250206861-A1 | COPOLYMER FOR SUPPRESSING PROTEIN ADSORPTION, METHOD FOR PRODUCING COPOLYMER, RESIN MODIFIER, MOLDING MATERIAL, COPOLYMER-CONTAINING COMPOSITION, COATING FILM, AND ARTICLE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-06-26 | — | — | US | claimed |
| US-12264212-B2 | Copolymer for suppressing protein adsorption, method for producing copolymer, resin modifier, molding material, copolymer-containing composition, coating film, and article | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-04-01 | — | — | US | claimed |
| EP-3858879-B1 | COPOLYMER FOR SUPPRESSING PROTEIN ADSORPTION, METHOD FOR PRODUCING COPOLYMER, RESIN MODIFIER, MOLDING MATERIAL, COPOLYMER-CONTAINING COMPOSITION, COATING FILM AND ARTICLE | MITSUBISHI CHEM CORP (JP) | 2025-01-01 | — | — | EP | claimed |
| EP-4446351-A1 | CURABLE COMPOSITION, MOLDED BODY, SILICONE HYDROGEL, METHOD FOR PRODUCING SILICONE HYDROGEL, AND MACROMONOMER | Mitsubishi Chemical Corporation (JP) | 2024-10-16 | — | — | EP | claimed |
| US-20240317908-A1 | CURABLE COMPOSITION, MOLDED BODY, SILICONE HYDROGEL, METHOD FOR PRODUCING SILICONE HYDROGEL, AND MACROMONOMER | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-26 | — | — | US | claimed |
| US-20240301193-A1 | RESIN COMPOSITION, PRODUCTION METHOD OF RESIN COMPOSITION, MOLDING MATERIAL, AND ARTICLE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-12 | — | — | US | claimed |
| WO-2020066685-A1 | COPOLYMER FOR SUPPRESSING PROTEIN ADHESION, METHOD FOR PRODUCING COPOLYMER, RESIN MODIFIER, MOLDING MATERIAL, COPOLYMER-CONTAINING COMPOSITION, COATING FILM AND ARTICLE | 三菱ケミカル株式会社 | 2020-04-02 | — | — | WO | claimed |
| US-9956324-B2 | Medical material, and medical device using the medical material | TERUMO KABUSHIKI KAISHA (JP) | 2018-05-01 | — | — | US | claimed |
| US-20170128636-A1 | MEDICAL MATERIAL, AND MEDICAL DEVICE USING THE MEDICAL MATERIAL | TERUMO KABUSHIKI KAISHA (JP) | 2017-05-11 | — | — | US | claimed |
| EP-1005452-B1 | ANIONIC ALKOXYLATE SURFACTANT | ORICA AUSTRALIA PTY LTD (AU) | 2004-03-17 | — | — | EP | claimed |
| US-6590030-B2 | Useful as stabilizer in preparation of aqueous dispersion of polymeric particles, or as substitute for alkylphenol based surfactants | ORICA AUSTRALIA PTY LTD (AU) | 2003-07-08 | — | — | US | claimed |
| US-20020061828-A1 | Anionic alkoxylate surfactant | DULUXGROUP (AUSTRALIA) PTY LTD (AU) | 2002-05-23 | — | — | US | claimed |
| EP-1005452-A4 | ANIONIC ALKOXYLATE SURFACTANT | ORICA AUSTRALIA PTY LTD (AU) | 2001-05-30 | — | — | EP | claimed |
| EP-1005452-A1 | ANIONIC ALKOXYLATE SURFACTANT | Orica Australia Pty Ltd (AU) | 2000-06-07 | — | — | EP | claimed |
| WO-1999007673-A1 | ANIONIC ALKOXYLATE SURFACTANT | ORICA AUSTRALIA PROPRIETARY LIMITED (AU) | 1999-02-18 | — | — | WO | claimed |
| US-4370368-A | WALLS CONTAINING AN ACRYLIC COPOLYMER OF VINYLIDENE CHLORIDE | TOYO SEIKAN KAISHA, LTD. (JP) | 1983-01-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008914-A1 | CURABLE COMPOSITION, MOLDED BODY, SILICONE HYDROGEL, AND METHOD FOR PRODUCING SILICONE HYDROGEL | SMCHD1, CRYAA, SMC2 | ALDH1A1 1283/4885TSHR 435/4885THRB 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.